Terms ending in 2032
Every in-force patent on Glytec, LLC's record whose computed term ends in 2032, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 9,483,619 | Means and Method For Improved Glycemic Control For Diabetic Patients In force · High confidence | Glytec, LLC | In force | High confidence | |
| US 9,773,096 | Means and Method For Improved Glycemic Control For Diabetic Patients In force · Medium confidence | Glytec, LLC | In force | Medium confidence | |
| US 9,811,638 | Means and Method For Improved Glycemic Control For Diabetic Patients In force · Medium confidence | Glytec, LLC | In force | Medium confidence | |
| US 9,965,596 | Means and Method for Improved Glycemic Control for Diabetic Patients In force · Medium confidence | Glytec, LLC | In force | Medium confidence | |
| US 10,102,922 | Means and Method For Improved Glycemic Control For Diabetic Patients In force · Medium confidence | Glytec, LLC | In force | Medium confidence | |
| US 10,410,740 | Means and Method for Improved Glycemic Control for Diabetic Patients In force · Medium confidence | Glytec, LLC | In force | Medium confidence | |
| US 10,629,294 | Means and Method for Improved Glycemic Control for Diabetic Patients In force · Medium confidence | Glytec, LLC | In force | Medium confidence | |
| US 11,131,643 | Method and System for Optimizing Insulin Dosages for Diabetic Subjects In force · High confidence | Glytec, LLC | In force | High confidence | |
| US 11,733,196 | System and Method for Optimizing Insulin Dosages for Diabetic Subjects In force · High confidence | Glytec, LLC | In force | High confidence | |
| US 9,171,343 | Means and Method for Improved Glycemic Control for Diabetic Patients In force · High confidence | Glytec, LLC | In force | High confidence | |
| 6 more term ends in 2032 · Pro | |||||
10 of 16 patents shown. Soonest term end first, then patent number.
Pro members see all 16.
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.